NICE recommends the use of alteplase within its marketing authorisation for treating acute ischaemic stroke in adults if treatment is started as early as possible within 4.5 hours of onset of stroke symptoms after intracranial haemorrhage has been excluded by appropriate imaging techniques (TA264). The SPC states that the treatment effect is time-dependent; therefore earlier treatment increases the probability of a favourable outcome.